Back to search
FDAFDA · Food and drugs·Recall number D-0878-2023

Tramadol Hydrochloride Tablets, USP 50 mg, Unit Dose 100-Count Tablets Rx only, Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), India. Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Distributed by: Major Pharmaceuticals Livonia, MI 48152 USA, NDC 0904-7179-61

Published July 5, 2023 · Recall initiated: June 16, 2023

Summary

FDA records drug Class II recall D-0878-2023, published July 5, 2023 and initiated June 16, 2023. Recalling firm: The Harvard Drug Group; Status: Terminated; Reported quantity: 3876 cartons; Lot: Lot #: M04343, Exp. 04/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Packaging defect: blister packaging inadequately sealed.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
The Harvard Drug Group
Distributor
Nationwide in the U.S.
Lot
Lot #: M04343, Exp. 04/2024
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Tramadol Hydrochloride Tablets, USP 50 mg, Unit Dose 100-Count Tablets Rx only, Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), India. Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Distributed by: Major Pharmaceuticals Livonia, MI 48152 USA, NDC 0904-7179-61 recalled?

Yes. FDA published recall D-0878-2023 on July 5, 2023. Reported hazard: Packaging defect: blister packaging inadequately sealed.

What should I do if I have this product?

Voluntary: Firm initiated · Letter